10-Year look at aneurysm device: will it hold up?

NCT ID NCT06990048

Ongoing Knowledge-focused Sponsor: Endologix Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 2000 people who received the AFX2 system, a device to repair abdominal aortic aneurysms. Researchers will track complications like rupture, need for further procedures, and death over 5 to 10 years. The goal is to see how well the device performs in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AFX2 System (a device used to repair abdominal aortic aneurysms)
What this could lead to: If successful, this study could provide real-world evidence on how well the AFX2 system works over the long term, helping doctors make better treatment decisions.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by factors other than the device. It does not test a new treatment, only gathers existing data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL AORTIC ANEURYSM

Contacts and locations

Locations

The Dartmouth Institute

Lebanon, New Hampshire, 03756, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.